TITLE

Prescription for growth

AUTHOR(S)
Parent, Tawn
PUB. DATE
August 1994
SOURCE
New Orleans CityBusiness (1994 to 2008);8/8/94, Vol. 15 Issue 5, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the B&H Pharmaceuticals company which has attracted the attention of a major capital firm. Dr. Nicolas Bazan and Lloyd Horrocks as the developers of B&H; Investment plans by MDS Health Ventures Inc. in B&H; Use of university research for marketable commodities; Good prospects for medical products; Future prospects for the company.
ACCESSION #
9410242291

 

Related Articles

  • Also for charity--are YOU up to it?  // Credit Management;Jun2005, p22 

    This article reports that AttentiV Systems has announced its sponsorship of the National Deaf Children's Society (NDCS) 24 Peak Challenge. Teams of 5 to 7 people will undertake the 31 mile challenge of scaling 24 peaks in the Lake District in just 24 hours. The peaks include Scafeil Pike,...

  • CDPHP adds product.  // Hudson Valley Business Journal;12/13/2004, Vol. 15 Issue 25, p12 

    The article reports that CDPHP has announced the addition of AttentiCare, an exclusive provider organization (EPO) pending regulatory approval, to its portfolio of health insurance products. AttentiCare was developed to provide large employer groups with cost-effective benefits very similar to...

  • COMPANY NEWS SHORT.  // Credit Management;May2004, p23 

    Lynx Financial Systems has announced its proposed flotation on the Alternative Investment Market of the London Stock Exchange in England. The company will be known as AttentiV Systems Group PLC but will continue trading as Lynx Financial Systems temporarily. AttentiV is expected to be valued at...

  • alarm filtering.  // Computer Desktop Encyclopedia;2015, p1 

    In network management, the ability to pinpoint the device that has failed. If one device in a network fails, others may fail as a result and cause alarms. Without alarm filtering, the management console reports all deteriorating devices with equal attenti

  • Nursing Begins to Look Better. Quinn, William T. // njbiz;6/16/2003, Vol. 16 Issue 24, p19 

    Reports on the efforts to make nursing profession attractive to students in the United States. Pharmaceutical companies involved in advertising campaigns to make nursing attractive; Increase of applications for nursing programs in New Jersey; Problems faced by nursing schools.

  • Pharma patents: India ranks second.  // Siliconindia;Sep2005, Vol. 9 Issue 8, p15 

    Reports on the increasing number of applications for patent of pharmaceutical products in India. Invention of critical life saving drugs by the pharmaceutical companies; Launch of drugs at a frenetic pace in Western countries; Attraction of international attention by the pharmaceutical firms...

  • MVPs. Roite, Bill; Williams, Daniel // Pharmaceutical Executive;Apr2005 Supplement, p22 

    Reports on the strategies used by pharmaceutical industries in attracting multicultural most valuable performers (MVP) to work in their companies. Benefit of the MVP for the companies; Importance of the use of multicultural MVP as a strategic business advantage over other companies; Factors...

  • Pfizer Signs Long-Term Generics Collaboration with Mylan in Japan. Cartwright, Heather // PharmaDeals Review;2012, Vol. 2012 Issue 9, p116 

    The article reports on a long-term collaboration between pharmaceutical companies Pfizer and Mylan to develop and market generic drugs in Japan. It states that the deal highlights the growth of the Japanese generic pharmaceutical market which attracts foreign businesses. It mentions that the...

  • OSI to retain 45 Cadus workers in Tarrytown. Khasru, B.Z. // Westchester County Business Journal;08/16/99, Vol. 38 Issue 33, p3 

    Reports on the merger between pharmaceutical firms OSI Pharmaceuticals Inc. and Cadus Pharmaceutical Corp. Company background; OSI Pharmaceuticals' plan to retain Cadus Pharmaceutical's employees.

  • Allergan criticizes Valeant. Investor's Business Daily // Investors Business Daily;5/28/2014, pA02 

    The article reports on the move of the pharmaceuticals company, Allergan Inc. to denounce the business strategy of pharmaceuticals company, Valeant Pharmaceuticals at an investor presentation.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics